<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40991192</PMID><DateRevised><Year>2025</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2584</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Sep</Month><Day>24</Day></PubDate></JournalIssue><Title>International urology and nephrology</Title><ISOAbbreviation>Int Urol Nephrol</ISOAbbreviation></Journal><ArticleTitle>Impact of continuous positive airway pressure therapy on metabolic and renal parameters in patients with obstructive sleep apnea, type 2 diabetes mellitus, and chronic kidney disease: a prospective cohort study.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11255-025-04777-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Continuous positive airway pressure (CPAP) therapy is the gold standard treatment for obstructive sleep apnea (OSA), but its impact on type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD), remains unclear. This study aimed to evaluate the effects of CPAP therapy on metabolic and renal parameters in patients with OSA, T2DM, and CKD for over 18&#xa0;months.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">This prospective, non-randomized, single-centre cohort study enrolled 60 patients with moderate-to-severe OSA (AHI&#x2009;&gt;&#x2009;15 episodes/hour), CKD (eGFR 15-60&#xa0;mL/min/1.73m<sup>2</sup>), and T2DM. The patients were divided into a CPAP therapy group (n&#x2009;=&#x2009;30) and a usual care group (n&#x2009;=&#x2009;30). CPAP adherence was defined as&#x2009;&#x2265;&#x2009;4&#xa0;h/night for at least 70% of monitored nights. The primary outcomes included changes in the urinary albumin-to-creatinine ratio (UACR) Secondary outcomes included changes in serum creatinine, estimated glomerular filtration rate (eGFR), HbA1c, homeostasis model assessment of insulin resistance (HOMA-IR), apnea-hypopnea index (AHI), and oxygen desaturation index (ODI). Statistical analyses included independent test, repeated measures of analysis of variance, and analysis of covariance (ANCOVA).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">8 (13%) patients were lost to follow-up, and therefore 52 patients (27 patients in CPAP group and 25 patients in usual care group) were included in per-protocol analysis. After 18&#xa0;months, CPAP therapy significantly improved AHI (mean change: 8.96&#x2009;&#xb1;&#x2009;4.94, p&#x2009;=&#x2009;0.001), HbA1c (mean change: 1.44&#x2009;&#xb1;&#x2009;0.46, p&#x2009;=&#x2009;0.001), HOMA-IR (mean change: 1.85&#x2009;&#xb1;&#x2009;0.14, p&#x2009;=&#x2009;0.001), UACR (mean change: 139.08&#x2009;&#xb1;&#x2009;85.27&#xa0;mg/g, p&#x2009;=&#x2009;0.015), and serum creatinine (mean change: 1.02&#x2009;&#xb1;&#x2009;0.34&#xa0;mg/dL, p&#x2009;=&#x2009;0.011). No significant changes were observed in eGFR (p&#x2009;=&#x2009;0.513) levels.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">CPAP therapy significantly improved metabolic and renal parameters, particularly albuminuria and insulin resistance, in patients with OSA, T2DM, and CKD. However, it did not significantly impact the eGFR over 18&#xa0;months.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s), under exclusive licence to Springer Nature B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saha</LastName><ForeName>Sohini</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0000-8869-2176</Identifier><AffiliationInfo><Affiliation>Department of General medicine, Institute of Medical Sciences and SUM Hospital, K8, Kalinga Nagar, Bhubaneswar, Odisha, 751003, India. sahasunny1803@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meher</LastName><ForeName>Meghanad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of General medicine, Institute of Medical Sciences and SUM Hospital, K8, Kalinga Nagar, Bhubaneswar, Odisha, 751003, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int Urol Nephrol</MedlineTA><NlmUniqueID>0262521</NlmUniqueID><ISSNLinking>0301-1623</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Albuminuria</Keyword><Keyword MajorTopicYN="N">Chronic kidney disease</Keyword><Keyword MajorTopicYN="N">Continuous positive airway pressure</Keyword><Keyword MajorTopicYN="N">Obstructive sleep apnea</Keyword><Keyword MajorTopicYN="N">Type 2 diabetes mellitus</Keyword></KeywordList><CoiStatement>Declarations. Conflict of interest: The authors declare no competing interests. Ethical approval and consent to participate: Ethical approval for the present study was obtained from the Siksha O Anusandhan Institutional Ethics Committee Biomedical Research and Studies (SUM/2021/IRB/MED/23). The study was conducted in strict accordance with the principles outlined in the Declaration of Helsinki and in compliance with all relevant guidelines and regulations governing human research ethics. Each patient provided written informed consent prior to participation.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>24</Day><Hour>13</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>24</Day><Hour>13</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>24</Day><Hour>11</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40991192</ArticleId><ArticleId IdType="doi">10.1007/s11255-025-04777-8</ArticleId><ArticleId IdType="pii">10.1007/s11255-025-04777-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lv R, Liu X, Zhang Y, Dong N, Wang X, He Y, Yue H, Yin Q (2023) Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome. Signal Transduct Target Ther 8(1):218. https://doi.org/10.1038/s41392-023-01496-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01496-3</ArticleId><ArticleId IdType="pubmed">37230968</ArticleId><ArticleId IdType="pmc">10211313</ArticleId></ArticleIdList></Reference><Reference><Citation>Abuyassin B, Sharma K, Ayas NT, Laher I (2015) Obstructive sleep apnea and kidney disease: a potential bidirectional relationship? J Clin Sleep Med 11(8):915&#x2013;924. https://doi.org/10.5664/jcsm.4946</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.4946</ArticleId><ArticleId IdType="pubmed">25845900</ArticleId><ArticleId IdType="pmc">4513269</ArticleId></ArticleIdList></Reference><Reference><Citation>National Kidney Foundation (2002) KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39(Suppl 1):S1&#x2013;S266</Citation></Reference><Reference><Citation>Suri TM, Ghosh T, Mittal S, Hadda V, Madan K, Mohan A (2023) Systematic review and meta-analysis of the prevalence of obstructive sleep apnea in Indian adults. Sleep Med Rev 71:101829. https://doi.org/10.1016/j.smrv.2023.101829</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smrv.2023.101829</ArticleId><ArticleId IdType="pubmed">37517357</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradshaw C, Gracious N, Narayanan R, Narayanan S, Safeer M, Nair GM, Murlidharan P, Sundaresan A, RetnarajSanthi S, Prabhakaran D et al (2018) Paying for hemodialysis in Kerala, India: a description of household financial hardship in the context of medical subsidy. Kidney Int Rep 4(3):390&#x2013;398. https://doi.org/10.1016/j.ekir.2018.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ekir.2018.12.007</ArticleId><ArticleId IdType="pubmed">30899866</ArticleId><ArticleId IdType="pmc">6409432</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess KR, Burgess EE, Whitelaw WA (1994) Impaired ventilatory response to carbon dioxide in patients with chronic renal failure: implications for the intensive care unit. Crit Care Med 22(3):413&#x2013;419. https://doi.org/10.1097/00003246-199403000-00010</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199403000-00010</ArticleId><ArticleId IdType="pubmed">8124991</ArticleId></ArticleIdList></Reference><Reference><Citation>Beecroft J, Duffin J, Pierratos A, Chan CT, McFarlane P, Hanly PJ (2006) Enhanced chemo-responsiveness in patients with sleep apnea and end-stage renal disease. Eur Respir J 28(1):151&#x2013;158. https://doi.org/10.1183/09031936.06.00075405</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.06.00075405</ArticleId><ArticleId IdType="pubmed">16510459</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok Y, Tan CW, Wong HS, How CH, Tan KL, Hsu PP (2017) Obstructive sleep apnoea and Type 2 diabetes mellitus: are they connected? Singapore Med J 58(4):179&#x2013;183. https://doi.org/10.11622/smedj.2017027</Citation><ArticleIdList><ArticleId IdType="doi">10.11622/smedj.2017027</ArticleId><ArticleId IdType="pubmed">28429032</ArticleId><ArticleId IdType="pmc">5392601</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordheim E, Jenssen TG (2021) Chronic kidney disease in patients with diabetes mellitus. Endocr Connect 10(5):R151&#x2013;R159. https://doi.org/10.1530/EC-21-0097</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EC-21-0097</ArticleId><ArticleId IdType="pubmed">33830068</ArticleId><ArticleId IdType="pmc">8111312</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Zhang W, Xin S, Yu X, Zhang X (2022) Effect of CPAP on blood glucose fluctuation in patients with type 2 diabetes mellitus and obstructive sleep apnea. Sleep Breath 26(4):1875&#x2013;1883. https://doi.org/10.1007/s11325-021-02556-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11325-021-02556-0</ArticleId><ArticleId IdType="pubmed">35165839</ArticleId><ArticleId IdType="pmc">9663373</ArticleId></ArticleIdList></Reference><Reference><Citation>Rimke AN, Ahmed SB, Turin TC, Pendharkar SR, Raneri JK, Lynch EJ, Hanly PJ (2021) Effect of CPAP therapy on kidney function in patients with chronic kidney disease: a pilot randomized controlled trial. Chest 159(5):2008&#x2013;2019. https://doi.org/10.1016/j.chest.2020.11.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.11.052</ArticleId><ArticleId IdType="pubmed">33316238</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Liu C, Zhang H, Zhang J, Zhao M, Sun D, Xia M, Han M (2019) Effect of 12-month nasal continuous positive airway pressure therapy for obstructive sleep apnea on progression of chronic kidney disease. Medicine (Baltimore) 98(8):e14545. https://doi.org/10.1097/MD.0000000000014545</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000014545</ArticleId><ArticleId IdType="pubmed">30813163</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamarr&#xf3;n E, Jaureguizar A, Garc&#xed;a-S&#xe1;nchez A, D&#xed;az-Cambriles T, Alonso-Fern&#xe1;ndez A, Lores V, Mediano O, Troncoso-Acevedo F, Cabello-Pelegr&#xed;n S, Morales-Ru&#xed;z E et al (2023) Continuous positive airway pressure effect on albuminuria progression in patients with obstructive sleep apnea and diabetic kidney disease: a randomized clinical trial. Am J Respir Crit Care Med 207(6):757&#x2013;767. https://doi.org/10.1164/rccm.202206-1091OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202206-1091OC</ArticleId><ArticleId IdType="pubmed">36342964</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamarr&#xf3;n E, Jaureguizar A, Garc&#xed;a-S&#xe1;nchez A, D&#xed;az-Cambriles T, Alonso-Fern&#xe1;ndez A, Lores V, Mediano O, Rodr&#xed;guez-Rodr&#xed;guez P, Cabello-Pelegr&#xed;n S, Morales-Ru&#xed;z E et al (2021) Obstructive sleep apnea is associated with impaired renal function in patients with diabetic kidney disease. Sci Rep 11(1):5675. https://doi.org/10.1038/s41598-021-85023-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-85023-w</ArticleId><ArticleId IdType="pubmed">33707611</ArticleId><ArticleId IdType="pmc">7952421</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU (2011) The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int 80(1):17&#x2013;28. https://doi.org/10.1038/ki.2010.483</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2010.483</ArticleId><ArticleId IdType="pubmed">21150873</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, Harrod CG (2017) Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 13(3):479&#x2013;504. https://doi.org/10.5664/jcsm.6506</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.6506</ArticleId><ArticleId IdType="pubmed">28162150</ArticleId><ArticleId IdType="pmc">5337595</ArticleId></ArticleIdList></Reference><Reference><Citation>American Diabetes Association (2011) Diagnosis and classification of diabetes mellitus. Diabetes Care 34(Suppl 1):S62&#x2013;S69. https://doi.org/10.2337/dc11-S062</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc11-S062</ArticleId><ArticleId IdType="pmc">3006051</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao MT, Sternbach JM, Guilleminault C (2017) Continuous positive airway pressure therapy in obstructive sleep apnea: benefits and alternatives. Expert Rev Respir Med 11(4):259&#x2013;272. https://doi.org/10.1080/17476348.2017.1305893</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17476348.2017.1305893</ArticleId><ArticleId IdType="pubmed">28287009</ArticleId></ArticleIdList></Reference><Reference><Citation>Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, Redline S, Henry JN, Getsy JE, Dinges DF (1993) Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 147(4):887&#x2013;895. https://doi.org/10.1164/ajrccm/147.4.887</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm/147.4.887</ArticleId><ArticleId IdType="pubmed">8466125</ArticleId></ArticleIdList></Reference><Reference><Citation>Jog KS, Eagappan S, Santharam RK, Subbiah S (2023) Comparison of novel biomarkers of insulin resistance with homeostasis model assessment of insulin resistance, its correlation to metabolic syndrome in South Indian population and proposition of population-specific cutoffs for these indices. Cureus. https://doi.org/10.7759/cureus.33653</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.33653</ArticleId><ArticleId IdType="pubmed">37593292</ArticleId><ArticleId IdType="pmc">10427510</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig CL, Marshall AL, Sj&#xf6;str&#xf6;m M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF et al (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35(8):1381&#x2013;1395. https://doi.org/10.1249/01.MSS.0000078924.61453.FB</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/01.MSS.0000078924.61453.FB</ArticleId><ArticleId IdType="pubmed">12900694</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong M, Guo F, Zhou T, Wei Q (2020) Association of diabetic nephropathy with the severity of obstructive sleep apnea-hypopnea syndrome in patients with type 2 diabetes mellitus. Endocr J 67(5):515&#x2013;522. https://doi.org/10.1507/endocrj.EJ19-0324</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ19-0324</ArticleId><ArticleId IdType="pubmed">32023571</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y, Lin J, Chen L, Chen X, Chen Q (2023) Meta-analysis of the effects of CPAP therapy on estimated glomerular filtration rate in patients with obstructive sleep apnea. Sleep Breath 27(6):2155&#x2013;2163. https://doi.org/10.1007/s11325-023-02811-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11325-023-02811-6</ArticleId><ArticleId IdType="pubmed">36940015</ArticleId></ArticleIdList></Reference><Reference><Citation>Molitoris BA, Reilly ES (2016) Quantifying glomerular filtration rates in acute kidney injury: a requirement for translational success. Semin Nephrol 36(1):31&#x2013;41. https://doi.org/10.1016/j.semnephrol.2016.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semnephrol.2016.01.008</ArticleId><ArticleId IdType="pubmed">27085733</ArticleId><ArticleId IdType="pmc">4834456</ArticleId></ArticleIdList></Reference><Reference><Citation>Abuyassin B, Badran M, Ayas NT, Laher I (2018) Intermittent hypoxia causes histological kidney damage and increases growth factor expression in a mouse model of obstructive sleep apnea. PLoS ONE 13(2):e0192084. https://doi.org/10.1371/journal.pone.0192084</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0192084</ArticleId><ArticleId IdType="pubmed">29389945</ArticleId><ArticleId IdType="pmc">5794148</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda T, Hirakawa Y, Nangaku M (2019) The role of oxidative stress and hypoxia in renal disease. Kidney Res Clin Pract 38(4):414&#x2013;426. https://doi.org/10.23876/j.krcp.19.063</Citation><ArticleIdList><ArticleId IdType="doi">10.23876/j.krcp.19.063</ArticleId><ArticleId IdType="pubmed">31558011</ArticleId><ArticleId IdType="pmc">6913586</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent BD, McNicholas WT, Ryan S (2015) Insulin resistance, glucose intolerance, and diabetes mellitus in obstructive sleep apnea. J Thorac Dis 7(8):1343&#x2013;1357. https://doi.org/10.3978/j.issn.2072-1439.2015.08.11</Citation><ArticleIdList><ArticleId IdType="doi">10.3978/j.issn.2072-1439.2015.08.11</ArticleId><ArticleId IdType="pubmed">26380761</ArticleId><ArticleId IdType="pmc">4561252</ArticleId></ArticleIdList></Reference><Reference><Citation>Oyama J, Yamamoto H, Maeda T, Ito A, Node K, Makino N (2012) Continuous positive airway pressure therapy improves vascular dysfunction and decreases oxidative stress in patients with the metabolic syndrome and obstructive sleep apnea syndrome. Clin Cardiol 35(4):231&#x2013;236. https://doi.org/10.1002/clc.21010</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.21010</ArticleId><ArticleId IdType="pubmed">22278815</ArticleId><ArticleId IdType="pmc">6652717</ArticleId></ArticleIdList></Reference><Reference><Citation>Awal HB, Nandula SR, Domingues CC, Dore FJ, Kundu N, Brichacek B, Fakhri M, Elzarki A, Ahmadi N, Safai S et al (2020) Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a randomized controlled trial. Cardiovasc Diabetol 19(1):72. https://doi.org/10.1186/s12933-020-01046-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-020-01046-z</ArticleId><ArticleId IdType="pubmed">32493344</ArticleId><ArticleId IdType="pmc">7271387</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanly PJ, Unruh ML (2023) Continuous positive airway pressure therapy for chronic kidney disease in patients with obstructive sleep apnea: the jury is still out. Am J Respir Crit Care Med 207(6):657&#x2013;659. https://doi.org/10.1164/rccm.202211-2171ED</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202211-2171ED</ArticleId><ArticleId IdType="pubmed">36480960</ArticleId></ArticleIdList></Reference><Reference><Citation>Vickers AJ, Altman DG (2001) Statistics notes: analysing controlled trials with baseline and follow up measurements. BMJ 323(7321):1123&#x2013;1124. https://doi.org/10.1136/bmj.323.7321.1123</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.323.7321.1123</ArticleId><ArticleId IdType="pubmed">11701584</ArticleId><ArticleId IdType="pmc">1121605</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>